Ondokuz Mayıs University, Department of Urology
Samsun, 55020, Turkey (Türkiye)
NCT Number: NCT05823545
This study aims to compare the strength of the classical Clavien-Dindo classification system (CDC), which is a Likert scale analysis versus the comprehensive complication index (CCI), a new quantitative evaluation system, in patients undergoing laparoscopic partial nephrectomy (LPN).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Samsun, 55020, Turkey (Türkiye)
Prospectively collected data of sixty-two patients undergoing LPN with postoperative complications from November 2009 to August 2020 were evaluated retrospectively. Postoperative complications were classified according to the CDCs and calculated using the CCI calculator (https://www.assessurgery.com) quantitatively. Major complications were determined as ≥ grade 3 complications according to the CDC. The complexity of the renal mass was defined according to the RENAL nephrometry score. The cut-off value for CCI was analyzed by the ROC analysis technique. The significance level was taken as p<0.05.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 3 months, postoperatively
Abnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up
Time frame: during the surgery (minute)
From first trocar incision to closure of all incisions
Time frame: during the surgery (mL)
perioperative estimated blood loss
Time frame: during the surgery (minute)
Its starts when the renal artery and vein are controlled and it ends when reperfusion of the graft kidney starts on the back table
Samsun Liv Hospital
Other
Which is Better to Assess Postoperative Complications in Patients Undergoing Laparoscopic Partial Nephrectomy?: Clavien-Dindo Classification Versus Comprehensive Complication Index.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03289962
Bladder Cancer, Breast Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT00458536
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial DetailsNCT03470285
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Angers, France
View Trial DetailsNCT07315100
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Amsterdam, North Holland, Netherlands
View Trial Details